Find clinical trials for Pancreatic Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Hanyang, Seoul, KOR:
as neoaduvant treatment in resectable or borderline resectable pancreatic cancer is feasible and efficacious.The combination of Dur...
Phase 2
Seoul, Korea, Republic of
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
Seoul, Korea, Republic of and 89 other locations
Pancreatic cancer is the 8th most prevalent cancer in Korea, and its 5-year overall survival rate has shown less than 10% ...
Phase 1
Seoul, Seoul, South Korea
in first line treatment naïve subjects with Stage IV metastatic pancreatic carcinoma. The first part of study will focus on the treatment of ...
Phase 1, Phase 2
Seoul, Korea, Republic of and 8 other locations
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
to therapy in first-line patients with unresectable or metastatic pancreatic cancer.Part A is a phase 1b dose-escalation design tha...
Phase 1, Phase 2
Seoul, Korea, Republic of and 11 other locations
treatment combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC).Two cohorts will be enrolled in parallel in t...
Phase 1, Phase 2
Seoul, Korea, Republic of and 26 other locations
of adjuvant Immuncell-LC therapy combined with gemcitabine versus adjuvant gemcitabine single therapy after R0 or R1 resection in patients with pancreatic...
Phase 3
Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Seoul, Seoul Teugbyeolsi, Korea, Republic of and 91 other locations
The purpose of this study is to confirm the recommended phase 2 dose (RP2D) of zolbetuximab in combination with Nab-P + GEM, determine overall surviv...
Phase 2
Seoul, Korea, Republic of and 137 other locations
A Phase 1b, Open-Label, Safety, Pharmacokinetic, and Pharmacodynamic Study of an Anti-super-enhancer Minnelide Once a Day on Days 1 to 5, Days 8 to 1...
Phase 1
Soeul, Korea, Republic of
Clinical trials
Research sites
Resources
Legal